Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease
- PMID: 10051466
- DOI: 10.1002/hep.510290347
Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease
Abstract
We characterized 70 consecutive patients with cryptogenic cirrhosis to assess major risks for liver disease. Each patient was reevaluated for past alcohol exposure, scored by the International Autoimmune Hepatitis (IAH) score and assessed for viral hepatitis risks and risks for nonalcoholic steatohepatitis (NASH). The results were compared with 50 consecutive NASH patients, 39 nonalcoholic patients age 50 and over with cirrhosis from hepatitis C, and 33 consecutive patients with cirrhosis caused by primary biliary cirrhosis (PBC). Among the cryptogenic group, 49 (70%) were female, and the mean age was 63 +/- 11 years. Although ascites and variceal bleeding were common, almost one half lacked major signs of complicated portal hypertension. A history of Type 2 diabetes mellitus and/or obesity was present in 51 (73%). Nineteen (27%) patients had a history of blood transfusions antedating the diagnosis of cirrhosis. No clinical or histological features distinguished this group from the other patients, and 14 (74%) of these had a history of obesity and/or diabetes. Nineteen of the remaining nontransfused patients had indeterminant IAH scores but were histologically and biochemically indistinguishable from the others. Twelve of these (63%) also had a history of obesity and/or diabetes. Both diabetes and obesity were significantly more common in the cryptogenic cirrhotic patients compared with the cirrhotic patients with PBC or hepatitis C. In contrast, the prevalence of obesity and diabetes was similar to the NASH patients who were, on average, a decade younger. Although there is some diversity that indicates more than one cause, our findings suggest that NASH plays an under-recognized role in many patients with cryptogenic cirrhosis, most of whom are older, type 2 diabetic and obese females.
Similar articles
-
Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study.Hepatology. 2000 Oct;32(4 Pt 1):689-92. doi: 10.1053/jhep.2000.17894. Hepatology. 2000. PMID: 11003611
-
Clinical characteristics of patients with cryptogenic liver cirrhosis in Okinawa, Japan.Hepatogastroenterology. 2003 Nov-Dec;50(54):2005-8. Hepatogastroenterology. 2003. PMID: 14696453
-
Prevalence of obesity, diabetes mellitus and hyperlipidaemia in patients with cryptogenic liver cirrhosis.Trop Gastroenterol. 2004 Jan-Mar;25(1):15-7. Trop Gastroenterol. 2004. PMID: 15303464
-
[Nonalcoholic steatohepatitis--current treatment options].Przegl Lek. 2006;63(2):91-4. Przegl Lek. 2006. PMID: 16967716 Review. Polish.
-
Non-alcoholic steatohepatitis in children.Pediatr Transplant. 2004 Dec;8(6):613-8. doi: 10.1111/j.1399-3046.2004.00241.x. Pediatr Transplant. 2004. PMID: 15598336 Review.
Cited by
-
Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis.Nat Rev Gastroenterol Hepatol. 2013 Jun;10(6):330-44. doi: 10.1038/nrgastro.2013.41. Epub 2013 Mar 19. Nat Rev Gastroenterol Hepatol. 2013. PMID: 23507799 Review.
-
Diagnosis and evaluation of nonalcoholic fatty liver disease.Exp Diabetes Res. 2012;2012:145754. doi: 10.1155/2012/145754. Epub 2011 Oct 27. Exp Diabetes Res. 2012. PMID: 22110476 Free PMC article. Review.
-
Nonalcoholic Fatty Liver Disease (NAFLD). Mitochondria as Players and Targets of Therapies?Int J Mol Sci. 2021 May 20;22(10):5375. doi: 10.3390/ijms22105375. Int J Mol Sci. 2021. PMID: 34065331 Free PMC article. Review.
-
Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals.Ann N Y Acad Sci. 2013 Apr;1281(1):106-22. doi: 10.1111/nyas.12016. Epub 2013 Jan 30. Ann N Y Acad Sci. 2013. PMID: 23363012 Free PMC article. Review.
-
Fructose as a key player in the development of fatty liver disease.World J Gastroenterol. 2013 Feb 28;19(8):1166-72. doi: 10.3748/wjg.v19.i8.1166. World J Gastroenterol. 2013. PMID: 23482247 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous